












Inna Thalmann
Founder at Mable
Inna is Co-Founder and COO of Mable - a precision medicine company using whole genome sequencing to optimise prescribing decisions. Prior to this, Inna completed her PhD in Econometrics with a focus on Health Economics at the University of Oxford, followed by postdoctoral research focused on the development of novel phenotype algorithms to increase the cost-efficiency of clinical trials.
Follow Inna
Alumnus of

University of Oxford

London School of Economics and Political Science
The American University of Paris